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Abstract
A diastereoselective auxiliary-mediated vinylation/[1,2]-Brook rearrangement/vinylogous Michael 
cascade of silyl glyoximide, vinylmagnesium bromide, and nitroalkenes is described. The reaction 
occurs with complete regio- and diastereocontrol in good yield. The diastereoselectivity is induced 
by a rare instance of 1,7-chirality transfer that is hypothesized to arise from a trans-multihetero-
decalin transition state.
Vinylogous reactivity provides a distinct and atom economical approach for the direct γ-
functionalization of carbonyls to synthesize complex targets. Prototypical cases involve the 
conversion of α,β-unsaturated carbonyls to their derived dienolates, or synthetic equivalents 
thereof, and electrophilic trapping at the γ-carbon. Although the vinylogous Mukaiyama 
aldol1 and Mannich2 reactions have become well-established, the vinylogous Michael 
reaction has received less attention.3 A key selectivity issue is the site of trapping in the 
extended π-system. Computational studies of frontier orbital densities and HOMO 
coefficients of simple lithium metallodienolates have established that α-trapping is favored 
over the γ-position.1a,4 The majority of examples of the vinylogous Michael reaction rely on 
substrates with an inherent preference for γ-selectivity relative to α-trapping: butenolides or 
α,α-dicyanoalkenes are commonly used.2
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Despite these challenges, some impressive examples of γ-functionalization via the 
vinylogous Michael reaction have been reported with various latent nucleophiles in the past 
five years. In 2010, Melchiorre and co-workers demonstrated that 3-alkylcyclohex-2-en-1-
ones could be employed as competent nucleophiles in highly regio- and enantioselective 
organocatalytic vinylogous Michael reactions with β-nitrostyrenes.5 Jørgenson then 
demonstrated the use of enals as acyclic latent dienolates in reactions with α-keto esters to 
construct dihydropyrans via formal [4 + 2] cycloaddition.6 Linear vinylogous Michael 
products were developed independently by Schnieder7 and Xu8 that expanded the 
vinylogous Mukaiyama Michael reaction (VMMR) to include aromatic α,β-unsaturated 
ketones with enals to provide valuable 1,7-dioxo compounds. In 2013, Wang and co-
workers described (salen)Mg-catalyzed vinylogous Michael additions between β-alkyl 
chalcones and β-nitrostyrenes to give nitrocyclohexanols in a formal [4 + 2] cycloaddition.9 
In general, the integration of functionality at the α-position is challenging, and the cases 
described above all rely on deprotonation of a latent dienolate precursor (Figure 1).
In 2010, we reported an alternative approach to the vinylogous Michael reaction by 
achieving the requisite dienolate via a vinylation/[1,2]-Brook rearrangement11 of silyl 
glyoxylates. The latter are a reliable class of conjunctive reagents for the union of 
nucleophilic and electrophilic partners.10 The title reaction was envisioned based on the 
seminal publications by the Kuwajima and Reich groups on silyloxyallyl- and 
silyloxypropargyl anionic systems.12 Addition of vinyl Grignard11 or acetylide13 
nucleophiles to silyl glyoxylates create (Z)-glycolate enolates14 that can either engage a 
secondary electrophile with either α- or γ-trapping. The identity of the secondary 
electrophile employed in silyl glyoxylate couplings functions as a regiochemical switch: 
carbonyl electrophiles provide predominantly α-adducts,15 whereas nitroalkenes and 
cyanoolefins provide exclusively γ-addition via trapping of an unusual α-keto ester 
homoenolate synthetic equivalent. Although the vinylogous Michael methodology provided 
good yields and complete regioselectivity favoring the γ-adduct, the utility was limited by 
the lack of stereoselectivity in forming the new chiral center.
Inducing asymmetry in the three-component couplings of silyl glyoxylates has been a topic 
of significant interest with instructive examples highlighted in Figure 2. Useful levels of 
diastereoselectivity (dr 15:1) were initially realized in the tandem Oppenauer oxidation/aldol 
reaction using an 8-phenylmenthol auxiliary. Although this result demonstrates that a chiral 
auxiliary at the ester moiety can provide high levels of selectivity, the selectivity was highly 
substrate dependent and could not be developed to include a wider scope.16 Schmitt et al. 
found similar substrate dependence in the glycolate Michael reaction: 5:1 diastereoselection 
was imparted by the chiral auxiliary. In independent reports, Greszler et al.17 and Yao and 
Lu18 demonstrated that chiral electrophiles can successfully provide high levels of 
stereoinduction via a proposed chairlike transition state. After several of our attempts to 
accomplish the vinylogous Michael cascade asymmetrically with silyl glyoxylate and chiral 
catalysts failed, a suitable chiral auxiliary was sought to confer asymmetry. Silyl 
glyoximides, a new class of acyl silanes developed by Hsung and co-workers, held promise 
as asymmetric conjunctive reagents.19
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Herein, we describe vinylation-initiated vinylogous Michael cascades of silyl glyoximides, 
nitroalkenes, and vinylmagnesium bromide. This work builds upon the initial finding 
reported in the original three-component coupling of silyl glyoxylates, vinyl Grignard, and 
nitroalkenes.11 The disclosed methodology affords (Z)-enolsilanes with complete regio- and 
diastereoselectivity by exploiting a rare example of long-range 1,7-chirality transfer to 
provide complete asymmetric induction. Compared to other vinylogous Michael 
methodologies, silyl glyoximides offer a conceptually distinct approach to the requisite 
dienolate nucleophile via a [1,2]-Brook rearrangement20 that provides α-heteroatom 
functionality currently inaccessible through other methods (Scheme 1). The three-
component coupling yields densely functionalized compounds, providing an enolsilane, 
nitro group, and acyl oxazolidinone21 in the product.
Because the synthesis of the desired silyl glyoximide 1 has been reported to provide a low 
yield,19 we sought to optimize the sequence (Scheme 2). We employed the aerobic oxidative 
carbamoylation protocol of Stahl and co-workers,22 which utilized a 5-fold excess of the 
oxazolidinone to provide a significant increase in yield from 23 to 74%. The excess of the 
oxazolidinone is required to inhibit homocoupling of the TES-alkyne; however, because the 
excess is not consumed in the reaction, the oxazolidinone can be recovered by flash 
chromatography. For the subsequent oxidation of the ynamide to the imido acyl silane, the 
reported 5 mol % catalyst loading was examined to minimize the use of the ruthenium 
complex. For this substrate, the catalyst loading could be decreased from 5 to 1 mol % of 
ruthenium(IV) oxide hydrate without adversely affecting the yield (81%). This two-step 
synthesis provides a 60% overall yield of the imido acyl silane, which compares favorably to 
the synthesis of the original silyl glyoxylate reagent.23
With a reliable synthesis of the primary electrophile in hand, the feasibility of the title 
process was investigated. An initial reaction of the imido acyl silane, β-nitrostyrene, and 
vinyl Grignard at −78 °C followed by warming to room temperature provided the desired 
three-component coupling product 3a in 47% yield as a single diastereomer. The absolute 
configuration was determined by conversion to the known γ-nitroaldehyde by ozonolysis.24 
Analysis of the byproducts demonstrated that vinylmagnesium bromide acts as a highly 
discriminating nucleophile in this reaction manifold with a strong preference for the acyl 
silane over the nitroalkene secondary electrophile: only trace quantities of direct Grignard 
addition to the nitroalkene were observed. Optimization revealed that a 50% excess of the 
nitroalkene improves the yield of the coupling to 75%. Unlike the related silyl glyoxylate 
coupling that required excess silyl glyoxylate to compensate for oligomerization,11 the 
imido acyl silane coupling produces no observable oligomerization. This absence of 
oligomerization may be due to several factors, including the added steric bulk of the chiral 
auxiliary and the altered electronics of the dienolate. The (Z)-geometry of the enolsilane was 
determined by analogy to the related enolsilanes from the silyl glyoxylate vinylogous 
Michael cascade.11 This (Z)-selectivity is also consistent with the homoenolate precedent set 
by the research groups of Reich and Kuwajima.12,14
With suitable conditions in hand, an examination of the allowable steric and electronic 
parameters of the coupling in the nitroalkene component was undertaken. A variety of alkyl, 
alkenyl, aryl, and heteroaryl nitroalkenes were submitted to the reaction conditions, and the 
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results are compiled in Table 1. The yields of three-component coupling products ranged 
from 40 to 75% with the ortho-substituted β-nitrostyrene substrates providing the lowest 
yields. Alkyl-, alkenyl-, and heteroaromatic-substituted nitroalkenes, as well as the 
piperonal-derived 3f and cinnamaldehyde-derived 3i, were well-tolerated. Nitrodiene 3i 
exhibited 1,4-selectivity in the face of potentially competing 1,6-addition, a circumstance 
that may provide a hint to the operative transition state of the three-component coupling 
(vide infra). All examples provided greater than 20:1 diastereoselectivity as judged by 1H 
NMR spectroscopic analysis of the unpurified reaction mixture. α-Substituted Grignard 
reagents (e.g., 2-propenylmagnesium bromide) were attempted, but productive three-
component coupling was not observed.
With high levels of stereoinduction for the vinylation coupling, we sought to utilize the silyl 
glyoximide to impart facial selectivity into the three-component alkynyl coupling previously 
reported by our group.13 Substituting the vinyl Grignard with an alkynyl Grignard was 
demonstrated to produce stereodefined silyloxyallenes 4 in a highly diastereoselective 
manner as illustrated in Scheme 3. Density functional theory (DFT) calculations supported a 
highly organized closed transition state where chelation between the nitro group and the 
metallodienolate enabled a fixed approach of the electrophile with respect to the (Z)-
glycolate enolate. Exposing the silyl glyoximide to the reported coupling conditions 
provided 5 as a 1:1 mix of two (of four possible) diastereomers (as judged by 1H NMR 
spectroscopic analysis of the unpurified reaction mixture).
Because 1,7-chiral induction is rare,25 we sought to understand the transition state that 
imparts such a high level of diastereoselectivity. A chelation-controlled model for this 
coupling would rely on nitroalkene activation by the Lewis acidic +MgBr portion of the (Z)-
metallodienolate to guide the approach of the former. We invoked a strong coordination 
effect of the nitro group to the magnesium counterion in a related silyl glyoxylate coupling 
with acetylides that was corroborated by DFT-calculations. This coordination was further 
empirically supported by the inability of a poor chelator, benzylidenemalononitrile, to 
perform with the same level of selectivity in the reaction.13 The electron-rich oxazolidinone 
can form a six-membered chelate to the magnesium counterion to provide rigidity and 
enforce facial selectivity from the oxazolidinone stereocenter. The nitroalkene approach can 
then be directed by coordination to the Lewis acid, creating a trans-decalin transition state 6 
as shown in Figure 3.
Significant precedent exists for such decalin transition states when multiple electronic 
interactions are possible.26 The multiheterobicyclo[4.4.0]decane framework of the transition 
state relies on the electrostatic interaction between the nitrogen and the electron-dense α-
position of the (Z)-metallodienolate. This orientation should also enable a stabilizing πC═C 
→ π*N═O interaction. This transition state would place the substituent of the nitroalkene 
into a desirable pseudoequatorial position that leads to the observed stereoisomer.
The three-component coupling of silyl glyoximide, vinylmagnesium bromide, and 
nitroalkenes to provide (Z)-enolsilanes with exceptional diastereoselectivity and good yields 
for a diverse substrate scope is disclosed. The high level of stereoinduction arising from a 
long-range 1,7-chiral transfer is hypothesized to be a result of a highly organized trans-
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decalin transition state. This reactivity pattern offers a unique complement to known acyclic 
vinylogous Michael methodologies by providing access to α-substituted linear products with 
a densely functionalized core. The (Z)-stereochemistry of the enolsilane prevents the Henry 
cyclization observed by Wang and co-workers, enabling the isolation of linear vinylogous 
products for the first time.
EXPERIMENTAL SECTION
General Information
Proton and carbon nuclear magnetic resonance spectra (1H and 13C NMR) were recorded at 
600 and 150 MHz, respectively, with solvent resonance as the internal standard (1H NMR: 
CDCl3 at 7.26 ppm; 13C NMR: CDCl3 at 77.0 ppm). 1H NMR data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = 
quartet, m = multiplet), coupling constants (Hz), and integration. Mass spectra were 
obtained using an FT-ICR mass analyzer with electrospray ionization. TLC visualization 
was accomplished with UV light and/or either aqueous potassium permanganate (KMnO4) 
or aqueous ceric ammonium molybdate (CAM) solution followed by heating. All reactions 
were carried out under an atmosphere of nitrogen in ovendried glassware with magnetic 
stirring. Yield refers to isolated yield of analytically pure material. Yields are reported for a 
specific experiment and as a result may differ slightly from those found in the tables, which 
are averages of at least two experiments. Dichloromethane, tetrahydrofuran, and toluene 
were dried by passage through a column of neutral alumina under nitrogen prior to use.27
Triethylsilyl Silyl Glyoximide (1)—Sodium carbonate (118.7 mg, 1.12 mmol, 2 equiv), 
CuCl2 (15.0 mg, 0.112 mmol, 0.2 equiv), and (R)-4-phenyloxazolidin-2-one (455.0 mg, 2.79 
mmol, 5 equiv) were added to an oven-dried round-bottom flask. The reaction flask was 
purged with O2 three times prior to the addition of toluene (3 mL, 0.2 M) and pyridine (0.09 
mL, 1.12 mmol, 2 equiv). A balloon of O2 was attached, and the reaction flask was placed in 
a preheated 70 °C oil bath. (Triethylsilyl)acetylene (0.10 mL, 0.56 mmol, 1 equiv) in toluene 
(3 mL, 0.2 M) was added dropwise over 6 h via syringe pump. The reaction was allowed to 
stir for 16 h and then cooled to room temperature and filtered through Celite. The crude 
mixture was concentrated in vacuo and then purified by flash chromatography with 25% 
EtOAc/hexanes to afford the requisite ynamide in 78% yield. The ynamide stains best with 
KMnO4 and ultraviolet light. The unreacted oxazolidinone can be recovered and reused by 
flushing the column with 100% EtOAc. The ynamide (390.0 mg, 1.29 mmol, 1 equiv) was 
then treated with NaIO4 (830.0 mg, 3.88 mmol, 3 equiv) and RuO2 hydrate (1.7 mg, 0.013 
mmol, 0.01 equiv) in a dichloromethane/acetonitrile/water (14 mL, 2/2/3 v/v) solution. The 
reaction was vigorously stirred for 3 h at room temperature, filtered through Celite, and 
concentrated in vacuo. The crude mixture was purified via silica plug (100% 
dichloromethane) to afford 370.0 mg (86%) of product 1 as a yellow solid. The title 
compound’s properties matched the reported characterization data.15
General Procedure for Synthesis of Nitroalkenes (2a–2l).28a—To the appropriate 
aldehyde (14.2 mmol) were added 2 mL of nitromethane and 25 mL of MeOH. This solution 
was cooled to 0 °C, and 35 mL of 1 M NaOH solution was added portionwise. The solution 
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was allowed to stir for 2 h and warm to room temperature. The mixture was then slowly 
added to an aqueous 6 M HCl solution cooled to 0 °C and stirred for 15 min. The mixture 
was washed with dichloromethane (3 × 15 mL). The organic layers were combined, washed 
with brine, dried over Na2SO4, and concentrated in vacuo. The crude mixture was purified 
by flash chromatography (10% EtOAc/hexanes) to afford the desired nitroalkene in yields 
ranging from 40 to 80% depending on the substrate. 1H NMR spectral data matched those 
reported in the literature.28
General Procedure for the Synthesis of Enolsilanes (3a–3l)—The silyl glyoximide 
and nitroalkene were added to an oven-dried vial. The vial was then purged with N2, and 
toluene (0.1 M) was added. The resulting solution was cooled to −78 °C using an 
acetone/dry ice bath, and vinylmagnesium bromide was added dropwise to the solution. 
Once the addition was complete, the reaction was allowed to warm to room temperature and 
stirred for 1 h; it was then diluted with diethyl ether (5 mL) and quenched with saturated 
ammonium chloride (5 mL). The resulting mixture was stirred for 10 min. The layers were 
separated, and the aqueous layer was extracted with ethyl acetate (3 × 10 mL). The organic 
extracts were combined, washed with brine (5 mL), dried with magnesium sulfate, and 
concentrated in vacuo. The crude mixture was purified by flash chromatography (25% 
EtOAc/hexanes) to afford products 3a–l
(R)-3-((S,Z)-6-Nitro-5-phenyl-2-((triethylsilyl)oxy)hex-2-enoyl)-4-phenyloxazolidin-2-
one (3a): The title compound was prepared according to the general procedure using imide 
1 (50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2a28a (33.6 mg, 0.225 mmol, 1.5 equiv), 
and vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), affording 57.4 mg (75%) 
of the product as a yellow oil. Analytical data for 3a: IR (thin film, cm−1) 3436, 3064, 3032, 
2957, 2913, 2877, 1785, 1692, 1644, 1552, 1381, 1320, 1204, 1157; 1H NMR (400 MHz, 
CDCl3) δ 7.41–7.24 (m, 10H), 5.51–5.47 (m, 2H), 4.75–4.63 (m, 3H), 4.26 (dd, J = 8.4, 7.2 
Hz, 1H), 3.70–3.62 (m, 1H), 2.71–2.55 (m, 2H), 0.97 (dd, J = 8, 7.6 Hz, 9H), 0.67 (q, J = 8 
Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 165.9, 153.0, 144.6, 139.3, 137.2, 129.1, 129.0, 
128.9, 127.7, 127.3, 126.4, 117.9, 79.5, 69.8, 58.5, 43.5, 29.6, 6.5, 5.2 ; TLC (20% EtOAc/
hexanes) Rf 0.36; HRMS (ESI+) calcd for C27H34N2O6Si+Na, 533.2084; found, 533.2099.
(R)-3-((S,Z)-6-Nitro-5-(o-tolyl)-2-((triethylsilyl)oxy)hex-2-enoyl)-4-phenyloxazolidin-2-
one (3b): The title compound was prepared according to the general procedure using imide 
1 (50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2b28a (38.0 mg, 0.225 mmol, 1.5 equiv), 
and vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), affording 44.0 mg (56%) 
of the product as a yellow oil. Analytical data for 3b: IR (thin film, cm−1) 2877, 2360, 1788, 
1380, 1204, 746, 528; 1H NMR (600 MHz, CDCl3) 7.34–7.18 (m, 9H), 5.46–5.38 (m, 2H), 
4.70–4.61 (m, 3H), 4.23–4.21 (m, 1H), 3.95–3.90 (m, 1H), 2.67–2.62 (m, 1H), 2.50–2.45 
(m, 1H), 2.32 (s, 3H), 0.93–0.90 (m, 9H), 0.64–0.60 (m, 6H); 13C NMR (125 MHz, CDCl3) 
δ 166.0, 153.1, 144.7, 137.4, 137.1, 136.3, 131.0, 129.2, 129.0, 127.4, 126.7, 126.4, 125.5, 
118.1, 79.1, 69.8, 58.5, 38.4, 29.2, 19.5, 6.6, 5.1; TLC (30% EtOAc/hexanes) Rf 0.51; 
HRMS (ESI+) calcd for C28H36N2O6Si+H, 525.2421; found, 525.2426.
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(R)-3-((S,Z)-6-Nitro-5-(p-tolyl)-2-((triethylsilyl)oxy)hex-2-enoyl)-4-phenyloxazolidin-2-
one (3c): The title compound was prepared according to the general procedure using imide 1 
(50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2c28a (38.0 mg, 0.225 mmol, 1.5 equiv), and 
vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), affording 45.0 mg (57%) of the 
product as a yellow oil. Analytical data for 3c: IR (thin film, cm−1) 3032, 2956, 2915, 2877, 
1787, 1693, 1552, 1458, 1320, 1204, 746, 701; 1H NMR (600 MHz, CDCl3) 7.39–7.11 (m, 
9H), 5.50–5.47 (m, 2H), 4.73–4.69 (m, 2H), 4.63–4.60 (m, 1H), 4.27–4.24 (m, 1H), 2.70–
2.65 (m, 1H), 2.55–2.50 (m, 2H), 2.37 (s, 3H), 0.96–0.93 (m, 9H), 0.67–0.63 (m, 6H); 13C 
NMR (125 MHz, CDCl3) δ 153.1, 144.6, 137.4, 137.1, 136.3, 129.7, 129.2, 129.1, 127.2, 
126.5, 118.4, 79.7, 69.9, 58.5, 43.3, 29.7, 21.1, 6.6, 5.1; TLC (30% EtOAc/hexanes) Rf 0.50; 
HRMS (ESI+) calcd for C28H36N2O6Si+Na, 547.2240; found, 547.2262.
(R)-3-((S,Z)-5-(o-Chlorophenyl)-6-nitro-2-((triethylsilyl)oxy)hex-2-enoyl)-4-
phenyloxazolidin-2-one (3d): The title compound was prepared according to the general 
procedure using imide 1 (50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2d28b (41.0 mg, 
0.225 mmol, 1.5 equiv), and vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), 
affording 35.0 mg (40%) of the product as a yellow oil. Analytical data for 3d: IR (thin film, 
cm−1) 2957, 2877, 1786, 1693, 1551, 1381, 1320, 1204, 1064, 1003, 747, 699; 1H NMR 
(600 MHz, CDCl3) 7.40–7.23 (m, 9H), 5.46–5.40 (m, 2H), 4.79–4.70 (m, 3H), 4.25–4.19 
(m, 2H), 2.69–2.63 (m, 2H), 0.92–0.89 (m, 9H), 0.63–0.59 (m, 6H); 13C NMR (125 MHz, 
CDCl3) δ 166.1, 153.1, 144.9, 137.1, 136.4, 134.0, 130.3, 129.2, 129.1, 128.8, 128.0, 127.4, 
126.4, 126.2, 117.4, 77.6, 69.9, 58.5, 39.7, 28.0, 6.6, 5.2; TLC (30% EtOAc/hexanes) Rf 
0.47; HRMS (ESI+) calcd for C27H33ClN2O6Si+Na, 567.1694; found, 567.1707.
(R)-3-((S,Z)-5-(p-Chlorophenyl)-6-nitro-2-((triethylsilyl)oxy)hex-2-enoyl)-4-
phenyloxazolidin-2-one (3e): The title compound was prepared according to the general 
procedure using imide 1 (50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2e28b (41.0 mg, 
0.225 mmol, 1.5 equiv), and vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), 
affording 49.0 mg (60%) of the product isolated as a yellow oil. Analytical data for 3e: IR 
(thin film, cm−1) 2957, 2360, 1791, 1698, 1557, 1038, 700, 536; 1H NMR (600 MHz, 
CDCl3) δ 7.37–7.26 (m, 7H), 7.14 (d, J = 9.0 Hz, 2H), 5.45 (dd, J = 8.4, 7.2, 1H), 5.38 (q, 
7.2 Hz, 1H), 4.72–4.68 (m, 1H) 4.61–4.59 (m, 1H), 4.27–4.24 (m, 1H), 3.61–3.56 (m, 1H), 
2.60–2.50 (m, 2H), 0.92–0.89 (m, 9H), 0.61–0.59 (m, 6H); 13C NMR (150 MHz, CDCl3) δ 
165.9, 153.1, 144.9, 137.8, 137.1, 133.6, 129.2, 129.2, 129.1, 128.7, 126.5, 117.2, 79.2, 
69.9, 58.5, 42.9, 29.5, 6.6, 5.2; TLC (30% EtOAc/hexanes) Rf 0.50; HRMS (ESI+) calcd for 
C27H33ClN2O6Si+Na, 567.1694; found, 567.1710.
(R)-3-((S,Z)-5-(Benzo[d][1,3]dioxol-5-yl)-6-nitro-2-((triethylsilyl)-oxy)-hex-2-enoyl)-4-
phenyloxazolidin-2-one (3f): The title compound was prepared according to the general 
procedure using imide 1 (50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2f28c (44.0 mg, 
0.225 mmol, 1.5 equiv), and vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), 
affording 46.0 mg (55%) of the product as a yellow oil. Analytical data for 3f: IR (thin film, 
cm−1) 2956, 2877, 2360, 1785, 1694, 1248, 1204, 1040, 745, 701; 1H NMR (600 MHz, 
CDCl3) 7.39–7.27 (m, 5H), 6.61 (d, J = 8.4 Hz, 1H), 6.68–6.64 (m, 2H), 5.95 (s, 2H), 5.47–
5.42 (m, 2H), 4.70 (t, J = 3.0 Hz, 1H), 4.65–4.62 (m, 1H), 4.55–4.51 (m, 1H), 4.26–4.22 (m, 
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1H), 3.53–3.49 (m, 1H), 2.62–2.59 (m, 1H), 2.46- 2.44 (m, 1H), 0.92–0.90 (m, 9H), 0.63–
0.59 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 166.0, 153.1, 148.1, 147.1, 144.7, 137.1, 
133.0, 129.2, 129.1, 126.5, 120.7, 118.1, 107.5, 101.2, 79.8, 69.9, 58.5, 43.4, 29.7, 6.6, 5.1; 
TLC (30% EtOAc/hexanes) Rf 0.47; HRMS (ESI+) calcd for C28H34N2O8Si+Na, 577.1982; 
found, 577.1995.
(R)-3-((R,Z)-5-(Thiophen-2-yl)-2-((triethylsilyl)oxy)hex-2-enoyl)-4-phenyloxazolidin-2-
one (3g): The title compound was prepared according to the general procedure using imide 
1 (50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2g28a (35.0 mg, 0.225 mmol, 1.5 equiv), 
and vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), affording 42.0 mg (54%) 
of the product isolated as a yellow oil. Analytical data for 3g: IR (thin film, cm−1) 2957, 
2877, 2360, 1785, 1695, 1379, 1204, 1013, 744, 700; 1H NMR (600 MHz, CDCl3) δ 7.37–
7.23 (m, 6H), 6.97–6.96 (m, 1H), 6.90 (d, J = 3 Hz, 1H), 5.51–5.46 (m, 2H), 4.72–4,69 (m, 
2H), 4.61–4.59 (m, 1H), 3.99–3.92 (m, 1H), 2.66–2.63 (m, 2H), 0.93–0.90 (m, 9H), 0.64–
0.60 (m, 6H); 13C NMR (150 MHz, CDCl3) δ 166.0, 153.1, 145.0, 142.3, 137.1, 129.2 
129.1, 127.1, 126.5, 125.3, 124.6, 117.3, 79.9, 69.9, 58.5, 39.0, 30.4, 6.6, 5.2; TLC (30% 
EtOAc/hexanes) Rf 0.36; LRMS (ESI+) calcd for C25H32N2O6SSi+Na, 539.17; found, 
539.26.
(R)-3-((R,Z)-5-(Furan-2-yl)-6-nitro-2-((triethylsilyl)oxy)hex-2-enoyl)-4-
phenyloxazolidin-2-one (3h): The title compound was prepared according to the general 
procedure using imide 1 (50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2h28b(32.0 mg, 
0.225 mmol, 1.5 equiv), and vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), 
affording 49.0 mg (65%) of the product isolated as an orange oil. Analytical data for 3h: IR 
(thin film, cm−1) 2957, 2877, 2360, 2341, 1787, 1693, 1555, 1379, 1321, 1204, 746, 700; 1H 
NMR (600 MHz, CDCl3) δ 7.37–7.30 (m, 7H), 6.32 (d, J = 1.8 Hz, 1H), 6.31(d, J = 1.8 Hz, 
1H), 6.15–6.14 (m, 1H), 5.50–5.45 (m, 3H), 4.72–4.71 (m, 1H), 4.26–4.23 (m, 1H), 2.62–
2.61 (m, 2H), 0.92–0.89 (m, 9H), 0.63–0.59 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 166.0, 
153.2, 152.2, 144.9, 142.3, 137.0, 129.2, 129.1, 126.5, 117.7, 110.4, 107.1, 69.9, 58.5, 37.2, 
27.1, 6.6, 5.1; TLC (30% EtOAc/hexanes) Rf 0.44; HRMS (ESI+) calcd for C25H32N2O7Si
+Na, 523.1876; found, 523.1893.
(R)-3-((S,2Z,6E)-5-(Nitromethyl)-7-phenyl-2-((triethylsilyl)oxy)-hepta-2,6-dienoyl)-4-
phenyloxazolidin-2-one (3i): The title compound was prepared according to the general 
procedure using imide 1 (50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2i28b (39.4 mg, 
0.225 mmol, 1.5 equiv), and vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), 
affording 55.5 mg (69%) of the product as a yellow oil. Analytical data for 3i: IR (thin film, 
cm−1) 2955, 2359, 1791, 1623, 1507, 1331, 1205, 742, 535; 1H NMR (600 MHz, CDCl3) 
7.37–7.25 (m, 10H), 6.98 (d, J = 16.2 Hz, 1H), 6.09–6.08 (m, 1H), 5.60–5.57 (m, 1H), 5.48–
5.42 (m, 1H), 4.71 (t,, J = 3.0 Hz, 1H), 4.53–4.52 (m, 1H), 4.52 (d,, J = 9.0 Hz, 1H), 4.26–
4.24 (m, 1H), 2.45–2.34 (m, 1H), 2.46–2.42 (m, 1H), 0.90–0.89 (m, 9H), 0.63–0.59 (m, 
6H); 13C NMR (125 MHz, CDCl3) δ 166.1, 153.2, 144.7, 137.1, 136.3, 133.3, 129.2, 129.1, 
128.6, 127.9, 127.1, 126.5, 118.1, 79.0, 69.9, 58.6, 41.7, 28.4, 6.7, 5.1; TLC (30% EtOAc/
hexanes) Rf 0.47; HRMS (ESI+) calcd for C29H36N2O6SiNa, 559.2240; found, 559.2255.
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(R)-3-((R,Z)-5-(Nitromethyl)-2-((triethylsilyl)oxy)hept-2-enoyl)-4-phenyloxazolidin-2-
one (3j): The title compound was prepared according to the general procedure using imide 1 
(50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2j28c (23.0 mg, 0.225 mmol, 1.5 equiv), and 
vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), affording 35.0 mg (51%) of the 
product isolated as a clear oil. Analytical data for 3j: IR (thin film, cm−1) 2959, 2877, 1789, 
1696, 1002, 744, 700, 533; 1H NMR (600 MHz, CDCl3) δ 7.40–7.33 (m, 5H), 5.60–5.57 (m, 
1H), 5.50–5.47 (m, 1H), 4.72 (t, J = 9 Hz, 1H), 4.38–4.32 (m, 2H), 4.28–4.25 (m, 1H), 2.40–
2.17 (m, 3H) 1.45 (q, J = 7.2 Hz, 2H), 0.98–0.89 (m, 12H), 0.63–0.59 (m, 6H); 13C NMR 
(150 MHz, CDCl3) δ 166.1, 153.3, 144.6, 137.1, 129.2 129.1, 126.4,, 119.3, 78.6, 69.8, 58.6, 
39.1, 26.9, 24.4, 10.8, 6.6, 5.2; TLC (20% EtOAc/hexanes) Rf 0.32; HRMS (ESI+) calcd for 
C23H34N2O6Si+Na, 485.2084; found, 485.2092.
(R)-3-((S,Z)-6-Methyl-5-(nitromethyl)-2-((triethylsilyl)oxy)hept-2-enoyl)-4-
phenyloxazolidin-2-one (3k): The title compound was prepared according to the general 
procedure using imide 1 (50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2k28c (29.0 mg, 
0.225 mmol, 1.5 equiv), and vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), 
affording 34.5 mg (71%) of the product as a pale yellow oil. Analytical data for 3k: IR (thin 
film, cm−1) 2459, 2877, 2360, 1788, 1693, 1550, 1383, 1205, 1004, 745, 700; 1H NMR (600 
MHz, CDCl3) δ 7.40–7.33 (m, 5H), 5.60–5.58 (m, 1H), 5.50–5.47 (m, 1H), 4.36–4.34 (m, 
1H), 4.31–4.25 (m, 3H), 2.39–2.15 (m, 3H), 1.88–1.68 (m, 1H), 0.95–0.88 (m, 15H), 0.62–
0.58 (m, 6H); 13C NMR (125 MHz, CDCl3) δ 166.1, 153.3, 144.7, 137.0 129.2, 129.1, 
126.5, 120.3, 69.9, 58.7, 41.7, 28.4, 6.7, 5.1; TLC (30% EtOAc/hexanes) Rf 0.59; HRMS 
(ESI) calcd for C24H36N2O6Si+H, 477.2421; found, 477.2451.
(R)-3-((R,Z)-7-Methyl-5-(nitromethyl)-2-((triethylsilyl)oxy)oct-2-enoyl)-4-
phenyloxazolidin-2-one (3l): The title compound was prepared according to the general 
procedure using imide 1 (50.0 mg, 0.150 mmol, 1.0 equiv), nitroalkene 2l28b (29.0 mg, 
0.225 mmol, 1.5 equiv), and vinylmagnesium bromide (0.23 mL, 0.230 mmol, 1.5 equiv), 
affording 45.0 mg (62%) of the product isolated as a clear oil. Analytical data for 3l: IR (thin 
film, cm−1) 2957, 2876,1787, 1693, 1383, 1205, 745, 700; 1H NMR (600 MHz, CDCl3) δ 
7.40–7.33 (m, 5H), 5.59 (t, J = 13.0 Hz, 1H), 4.82 (dd, J = 8.4, 7.8 Hz, 1H), 4.72 (t, J = 9.0 
Hz, 1H), 4.36–4.25 (m, 3H), 2.41–2.38 (m, 2H), 2.18–2.16 (m, 1H), 1.67–1.66 (m, 1H), 
1.38–1.15 (m, 2H), 0.92–0.89 (m, 15H), 0.63–0.59 (m, 6H); 13C NMR (150 MHz, CDCl3) δ 
166.1, 153.2, 144.6, 137.2, 129.2, 129.0, 126.4, 119.1, 79.1, 69.8, 58.6, 40.9, 35.5, 27.6, 
25.1, 22.7, 22.3, 6.7, 6.6, 5.2, 5.2; TLC (20% EtOAc/hexanes) Rf 0.39; HRMS (ESI+) calcd 
for C25H38N2O6Si+H, 491.2577; found, 491.2600.
(S)-4-Nitro-3-phenylbutanal
A 20 mL scintillation vial was charged with 3a (35 mg, 0.069 mmol, 1.0 equiv) and CH2Cl2 
(1.0 mL, 0.07 M). Ozone was bubbled through the solution at −78 °C until the solution 
turned a light blue. The reaction was then purged with N2 for 15 min until the color 
dissipated. Dimethyl sulfide (0.08 mg, 0.135 mmol, 5.0 equiv) was added to the reaction 
mixture and warmed to room temperature. Once the reaction was complete, the solution was 
diluted with CH2Cl2 (5 mL) and H2O (5 mL). The layers were separated, and the aqueous 
layer was extracted with methylene chloride (3 × 5 mL). The combined organic extracts 
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were washed with brine (5 mL), dried with sodium sulfate, and concentrated in vacuo. The 
crude mixture was purified by flash chromatography (30% EtOAc/hexanes) to provide 13.4 
mg (52%) of the product as a colorless oil. 1H NMR spectral data matched those reported for 
the title compound;24a [α]D −24 (c 0.71, CHCl3).
(S)-4-Nitro-3-phenylbutan-1-ol
A 20 mL scintillation vial was charged with 3a (14 mg, 0.027 mmol, 1.0 equiv) and CH2Cl2 
(1.0 mL, 0.03 M). Ozone was bubbled through the solution at −78 °C until the solution 
turned a light blue. The reaction was then purged with N2 for 15 min until the color 
dissipated. NaBH4 (3.11 mg, 0.082 mmol, 3.0 equiv) was added, and the reaction was 
warmed to room temperature. Once the reaction was complete, the solution was diluted with 
CH2Cl2 (5 mL) and H2O (5 mL). The layers were separated, and the aqueous layer was 
extracted with methylene chloride (3 × 5 mL). The combined organic extracts were washed 
with brine (5 mL), dried with sodium sulfate, and concentrated in vacuo. The crude mixture 
was purified by flash chromatography (30% EtOAc/hexanes) to provide 4 mg (75%) of the 
product as a colorless oil. 1H NMR spectral data matched those reported for the title 
compound.24b SFC analysis showed a 96:4 er for the product.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Dienolate synthon: selected synthetic equivalents.
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Figure 2. 
Diastereoselective silyl glyoxylate couplings.
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Figure 3. 
Proposed trans-decalin transition state.
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Scheme 1. 
Vinylmagnesium Bromide-Initiated Vinylogous Coupling of Silyl Glyoximide with 
Nitroalkenes
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Scheme 2. 
Optimized Synthesis of Silyl Glyoximide 1
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Scheme 3. 
Comparison of Diastereoselectivity between Silyl Glyoxylates and Silyl Glyoximides
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Table 1
Synthesis of (Z)-Enolsilanes via Three-Component Coupling
entrya product R yield (%)b drc
1 3a Ph 75 >20:1
2 3b o-MeC6H5 56 >20:1
3 3c p- MeC6H5 61 >20:1
4 3d o-ClC6H5 40 >20:1
5 3e p-ClC6H5 60 >20:1
6 3f piperonyl 57 >20:1
7 3g 2-thienyl 54 >20:1
8 3h 2-furyl 70 >20:1
9 3i (E)-CH═CHPh 69d >20:1
10 3j Et 56 >20:1
11 3k iPr 63 >20:1
12 3l CH2iPr 62 >20:1
aAll reactions were conducted with [1]0 = 0.1 M.
b
Isolated yield.
c
Diastereomeric ratio estimated from integration of 1H NMR spectra of unpurified mixtures.
dApproximately 85% purity.
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